Food and Drug Administration's Obesity Drug Guidance Document: a short history.

Authors :: Colman E
Source :: Circulation [Circulation] 2012 May 01; Vol. 125 (17), pp. 2156-64.
Publication Year :: 2012

Subjects :: Adolescent
Adult
Advisory Committees history
Aged
Anti-Obesity Agents adverse effects
Anti-Obesity Agents therapeutic use
Bariatric Medicine history
Body Mass Index
Child
Congresses as Topic history
Cyclobutanes therapeutic use
Diabetes Mellitus, Type 2 epidemiology
Drug Approval
Drug Discovery
Female
History, 20th Century
History, 21st Century
Humans
Male
Middle Aged
Multicenter Studies as Topic
Obesity epidemiology
Obesity history
Outcome Assessment, Health Care
Piperidines adverse effects
Piperidines therapeutic use
Practice Guidelines as Topic
Pyrazoles adverse effects
Pyrazoles therapeutic use
Randomized Controlled Trials as Topic
Reference Standards
Rimonabant
Safety-Based Drug Withdrawals
United States epidemiology
Anti-Obesity Agents history
Obesity drug therapy
United States Food and Drug Administration history

Full Text Access

Tools